Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors

NCT07586826 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Persistent Isolated Chemotherapy-Induced Thrombocytopenia
Chemotherapy-Induced Thrombocytopenia
Gynecologic Cancers
Ovarian Cancer
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cervical Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer

Interventions

DRUG: Romiplostim N01
DRUG: All-trans retinoic acid

Sponsor

Peking University People's Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]